In this fascinating interview, CEO Bram Goorden of
IXICO - an AI powered medical imaging analytics firm helping Biopharma groups develop new treatments for neurodegenerative diseases – kindly takes me through today’s inline H1’25 trading update and positive outlook.
Disclosure: I own shares in IXICO, who is also a Vox Markets client.
In this fascinating interview, CEO Bram Goorden of
IXICO - an AI powered medical imaging analytics firm helping Biopharma groups develop new treatments for neurodegenerative diseases – kindly takes me through today’s inline H1’25 trading update and positive outlook.
Disclosure: I own shares in IXICO, who is also a Vox Markets client.